Yahoo
Shanghai - Delayed Quote CNY

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)

25.30 +0.81 (+3.31%)
At close: 3:00:01 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,990,318.13
3,866,608.23
3,728,023.67
3,136,746.41
3,532,379.04
Cost of Revenue
2,126,496
1,964,792.80
1,992,486.63
1,822,074.22
2,034,199.79
Gross Profit
1,863,822.13
1,901,815.44
1,735,537.04
1,314,672.19
1,498,179.25
Operating Expense
1,172,817.37
1,232,088
1,116,528.59
898,486.12
971,438.03
Operating Income
691,004.77
669,727.43
619,008.45
416,186.07
526,741.22
Net Non Operating Interest Income Expense
12,678.08
32,987.54
57,598.86
44,320.95
46,278.19
Pretax Income
727,493.13
709,000.78
657,553.69
524,703.24
559,135.16
Tax Provision
106,918.55
103,290.07
109,255.20
72,864
79,784.04
Net Income Common Stockholders
594,829.34
581,492.37
528,093.86
443,250.94
478,571.95
Basic EPS
1.38
1.35
1.23
1.03
1.11
Diluted EPS
1.38
1.35
1.23
1.03
1.11
Basic Average Shares
430,974.46
430,735.09
429,344.60
430,340.71
431,145.90
Diluted Average Shares
430,974.46
430,735.09
429,344.60
430,340.71
431,145.90
Total Operating Income as Reported
737,010.15
719,868.05
666,822.02
536,628.34
555,538.27
Rent Expense Supplemental
5,746.85
4,530.75
5,671.27
5,615.01
5,408.60
Total Expenses
3,299,313.37
3,196,880.80
3,109,015.22
2,720,560.33
3,005,637.82
Net Income from Continuing & Discontinued Operation
594,829.34
581,492.37
528,093.86
443,250.94
478,571.95
Normalized Income
596,055.36
592,254.94
547,598.14
455,696.29
528,193.95
Interest Income
18,220.81
40,436.97
65,218.02
60,980.29
58,562.81
Interest Expense
4,925.82
7,380.15
7,376.55
16,854.17
11,687.93
Net Interest Income
12,678.08
32,987.54
57,598.86
44,320.95
46,278.19
EBIT
732,418.95
716,380.93
664,930.25
541,557.40
570,823.09
EBITDA
732,418.95
810,775.03
745,931.39
622,120.72
649,333.17
Reconciled Cost of Revenue
2,126,496
1,964,792.80
1,992,486.63
1,822,074.22
2,034,199.79
Reconciled Depreciation
86,843.61
94,394.10
81,001.14
80,563.31
78,510.08
Net Income from Continuing Operation Net Minority Interest
594,829.34
581,492.37
528,093.86
443,250.94
478,571.95
Total Unusual Items Excluding Goodwill
-1,437.24
-12,597.87
-23,390.75
-14,452.31
-57,881.17
Total Unusual Items
-1,437.24
-12,597.87
-23,390.75
-14,452.31
-57,881.17
Normalized EBITDA
733,856.19
823,372.91
769,322.13
636,573.02
707,214.34
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-211.23
-1,835.31
-3,886.47
-2,006.95
-8,259.17
12/31/2022 - 5/17/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: